Funder: Alzheimer's Drug Discovery Foundation
Due Dates: January 12, 2026 (Invited full proposal) | September 14, 2026 (Letter of Intent)
Funding Amounts: Up to $5,000,000 per project; multi-year awards; milestone-based payments
Summary: Supports IND-enabling studies and early-phase clinical trials for innovative drugs and devices targeting Alzheimer's and related dementias.
Key Information: Only direct costs are allowed; mission-related investment model with return on investment required.